Clinical Trial Update: Effect of Metabolic Modulation on a Post-acute COVID-19 Vaccination Syndrome (PACVS) Cohort [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating metabolic modulation for Post-acute COVID-19 syndrome; currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute COVID-19 Syndrome

Snippet

Sponsor: Independent Medical Alliance | Conditions: Vaccine Adverse Reaction, Post Acute Covid-19 Vaccination Syndrome | Phase 2 | Status: NOT_YET_RECRUITING